Home › Vivus - Flat Qsymia Scripts Point To Needed Shift
 

Keywords :   


Vivus - Flat Qsymia Scripts Point To Needed Shift

2015-03-02 21:52:57| Biotech - Topix.net

It is no secret that the Vivus's anti-obesity pill Qsymia have been pretty flat for over a year. If a flat sales trajectory is not troubling enough, the fact that Contrave from Orexigen is about to overtake Qsymia in just about 20 or 21 weeks should be a clear signal that a change is needed.

Tags: point needed flat shift

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
More »